| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 60,337 | 60,842 | 58,288 | 58,625 | | Cost of Revenue | 26,902 | 26,927 | 26,072 | 26,766 | | | Gross Profit | 33,435 | 33,915 | 32,216 | 31,859 | | | Operating Expenses | | Research Development | 8,996 | 8,973 | 8,172 | 7,831 | | Selling General and Administrative | 13,078 | 16,916 | 11,338 | 17,427 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,298 | 2,427 | 2,573 | 2,381 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,063 | 5,599 | 10,133 | 4,220 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (10) | 10 | 894 | | Earnings Before Interest And Taxes | 8,029 | 5,589 | 10,143 | 5,114 | | Interest Expense | (518) | 518 |
-
| 855 | | Income Before Tax | 8,547 | 5,071 | 10,143 | 4,259 | | Income Tax Expense | 1,637 | 440 | 1,199 | (1,074) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,910 | 4,631 | 8,944 | 5,333 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,910 | 4,631 | 8,944 | 5,333 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,910 | $4,631 | $8,944 | $5,333 |
|
0.11% Nasdaq 
0.01%
Income Statement
